Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(11), P. 1350 - 1350
Published: Oct. 22, 2024
: The emergence of resistance to
Language: Английский
Macromolecules, Journal Year: 2025, Volume and Issue: unknown
Published: April 4, 2025
Language: Английский
Citations
0
Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 162088 - 162088
Published: April 1, 2025
Language: Английский
Citations
0
Elsevier eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 299 - 392
Published: Aug. 30, 2024
Language: Английский
Citations
2
Materials Today Bio, Journal Year: 2024, Volume and Issue: 29, P. 101255 - 101255
Published: Sept. 17, 2024
Language: Английский
Citations
2
Microorganisms, Journal Year: 2024, Volume and Issue: 12(8), P. 1650 - 1650
Published: Aug. 12, 2024
The unresolved challenges in the development of highly efficient, stable and controlled synthetic microbial consortia, as well use natural are very attractive for science technology. However, consortia management should be done with knowledge how not only to accelerate but also stop action such "little pots". Moreover, there a lot activity which suppressively controlled. processes, catalyzed by various microorganisms being complex slowed down or completely cancelled, typical environment (biocorrosion, landfill gas accumulation, biodegradation building materials, water sources deterioration etc.), industry (food biotechnological production), medical practice (vaginitis, cystitis, intestinal dysbiosis, etc.). search ways suppress functioning heterogeneous each these areas is relevant. purpose this review summarize general trends studies regarding targets new means influence used. analysis features applied approaches solving main problem confirms possibility obtaining combined effect, selective on individual components consortia. Of particular interest role viruses suppressing different compositions.
Language: Английский
Citations
1
International Journal of Nanomedicine, Journal Year: 2024, Volume and Issue: Volume 19, P. 11883 - 11921
Published: Nov. 1, 2024
Chronic wound infection has become a global health problem, with bacterial biofilms, which are difficult to penetrate using traditional antibiotics, considered the primary cause of recurrent and delayed healing in chronic wounds. In recent years, outstanding performance nanomaterials controlling biofilm infections been widely acknowledged, these materials regarded as highly promising for management. The formation structure biofilms undergo complex dynamic changes. Therefore, deep understanding underlying causes repeated specific antibacterial mechanisms at different stages is crucial effective "chronic management". This review first reveals relationship between chronicity, infections. Secondly, it focuses on four formation: (1) adhesion stage, (2) aggregation promotion (3) maturation (4) regeneration dissemination stage. It also comprehensively summarizes nanomaterials. study analyzes essential factors affecting control by nanoparticles from various perspectives, such material itself, local environment, systemic host response. Finally, limitations potential future trends current research discussed. summary, represent strategy combating infections, this provides new insights alternative adjuvant therapies managing
Language: Английский
Citations
1
Acta Pharmaceutica Sinica B, Journal Year: 2024, Volume and Issue: 15(1), P. 97 - 122
Published: Dec. 14, 2024
Cancer remains a complex and challenging medical problem, driving extensive research efforts. Despite significant progress in understanding its genetic molecular aspects, the quest for effective treatments continues. Nanomedicines have shown great potential revolutionizing cancer treatment by offering targeted controlled drug delivery, reducing side effects, improving patient outcomes. Accordingly, nanomedicines been focus of development clinical translation. As September 2024, search on ClinicalTrials.gov website using term "nanoparticles" revealed numerous ongoing planned trials. Motivated recent advances field, this review explores current frontier nanomedicine. supported chemotherapy, phototherapy sonodynamic therapy, nucleic acid immunotherapy. However, translating into practice has challenged interactions between nanoparticles biological systems, variable permeability retention tumors, safety concerns, difficulty achieving issues with scaling up manufacturing. Perspectives addressing these challenges are offered. Future opportunities nanomedicines, including modifying tumor microenvironment, integrating artificial intelligence big data, targeting new areas, also discussed. This underscores to revolutionize from standpoint.
Language: Английский
Citations
1
Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(11), P. 1350 - 1350
Published: Oct. 22, 2024
: The emergence of resistance to
Language: Английский
Citations
0